Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | PARP1 | P09874 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10475746 | 1.00 | ALOX15 (0.37) | ALOX15ALDH1A1TSHRLMNAGAA | |
| SCHEMBL18118469 | 1.00 | ALOX15 (0.37) | ALOX15ALDH1A1TSHRLMNAGAA | |
| SCHEMBL12238070 | 0.94 | LMNA (0.36) | ALOX15ALDH1A1TSHRLMNAGAA | |
| SCHEMBL437100 | 0.94 | LMNA (0.36) | ALOX15ALDH1A1TSHRLMNAGAA | |
| SCHEMBL12094406 | 0.87 | POLB (0.38) | KMT2ARECQLMEN1 | |
| SCHEMBL20750016 | 0.87 | KMT2A (0.41) | ALDH1A1LMNAGAAKMT2AKDM4E | |
| SCHEMBL26382118 | 0.85 | SMN1; SMN2 (0.33) | ALDH1A1TSHRLMNASMN1; SMN2KDM4E | |
| SCHEMBL15518427 | 0.85 | HSD17B10 (0.39) | ALDH1A1TSHRSMN1; SMN2KMT2AMEN1 | |
| SCHEMBL560792 | 0.85 | HSD17B10 (0.39) | ALDH1A1TSHRSMN1; SMN2KMT2AMEN1 | |
| SCHEMBL1241402 | 0.83 | GAA (0.41) | ALDH1A1GAASMN1; SMN2KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110003395-A1 | SPECIFIC ANALYSIS OF ANALYTES USING REAGENT COMPOUNDS, LABELING STRATEGIES, AND MASS SPECTROMETRY WORKFLOW | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) | 2011-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110003395-A1 | SPECIFIC ANALYSIS OF ANALYTES USING REAGENT COMPOUNDS, LABELING STRATEGIES, AND MASS SPECTROMETRY WORKFLOW | HSD17B7, HSD17B13, HSD11B1 | ALOX15 373/4885ALDH1A1 70/4885TSHR 2467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.